Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

The government-funded study was small and experts say it's not yet clear how safe these drugs are for people who don't need ...

Compounded weight-loss medications such as those promoted in the Hims & Hers commercial aren’t approved by the Food and Drug ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Sales of weight loss drug Wegovy more than doubled in the final three months of 2024, as manufacturer Novo Nordisk predicted growth will slow this year. The Danish pharmaceutical company has ...

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs. Net profit for the fourth ...

Wegovy maker Novo Nordisk on Wednesday forecast sales would grow at a slower rate this year although the outlook was roughly in line with market expectations as the pace of ferocious demand for its ...

Investing.com -- Novo Nordisk 's (CSE:NOVOb) stock jumped over 3% on Wednesday following a stronger-than-expected fourth-quarter profit, boosted by an increase in sales of Wegovy, the company's weight ...